NRAS and neoplasm: Further evidence in support of a role of SASP in senescence‐mediated tumour suppression was provided using a NRas‐driven hepatoma model where blockade of cGAS‐STING‐mediated production of pro‐inflammatory SASP impaired the immunosurveillance‐mediated clearance of NRasG12V‐expressing hepatocytes, resulting in intrahepatic tumorigenesis [29].